Disclaimer: the below is about a course that's entirely free, no credit cards, no trials, no bullshit.
It's not a very well known fact that it's legal to get access to a medicine that was just recently approved or still in clinical trials, there are various ways to do that. I'd like to offer a little information about that.
-
Clinical trials: everybody knows this, you can participate in a clinical trial testing a new medicine. This is free for the patient.
-
Early Access Programs: pharma companies have programs that allow doctors to enter individual patients or cohorts of patients (usually for no cost) and start a treatment that was just recently approved or is in the final stage in clinical trials. They usually ask to monitor the patient over the course of the treatment so they have additional data about the effects on the general population (outside the constraints of a clinical trial). Some Programs are different in some ways, but this is the gist of it.
-
Named Patient basis: most countries in the world have legal exceptions that allow the import of an unapproved medicine (it has to be approved somewhere in the world though) into the country based on a doctor prescription and likely a lot of paperwork, depending on country. The costs are usually completely covered by the patient, this is nowhere near free. Some insurance companies cover this however or reimburse the patient after the fact.
I wrote, with the aid of a lawyer and 2 sourcing and logistics experts, a course that explains these options. It’s all only written content and it’s self-paced - and entirely free, no credit cards, no trials, no bullshit.
https://learn.everyone.org/courses/medicine-access-masterclass
Disclaimer: I work for a medical company that sells medicines in countries where the medicines are not yet approved - we work on a Named Patient basis as explained above. We built this course to help inform more people of their options and, of course since there has to be a gain for the company, to get our name out there.
I am leaving the company, but since I wrote this course and I believe it's valuable information, I was thrilled that management made it free (not sure if temporarily or permanently however) and I am able to put it out there. Maybe it helps someone. Maybe it doesn't, but at least some people might learn of other options they never knew about. I truly hope it does some good.
Chapters:
Chapter 1: Regulatory agencies and their responsibilities towards patients
Chapter 2: Availability is not access: Unequal medicine access after approval
Chapter 3: Exceptions to the regulatory process
Chapter 4: Accessing medicines still in development: Enrolling in clinical trials
Chapter 5: Accessing medicines still in development: Early Access Programs
Chapter 6: Accessing medicines that are approved somewhere in the world, but not locally: Personal import (Named Patient basis)
Chapter 7: Risk and liability for physicians
Chapter 8: Challenges patients face when trying to access unapproved medicines
https://ift.tt/bB7QeDj Submitted November 17, 2022 at 08:24PM by pixielady https://ift.tt/S0DXT9x